Johnson Matthey plans to close its fine chemical manufacturing facility in Ireland and consolidate manufacturing of prostaglandin products at its US facility. The company said that in the quarter to the end of March its Fine Chemicals & Catalysts Division's sales excluding precious metals were ahead of the same period last year helped by favourable exchange translation and that good sales of active pharmaceutical ingredients offset some weakness in catalysts and chemicals.
Reuters
Thursday 2 April 2009
Johnson Matthey to close Irish plant
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment